These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 19712175)

  • 61. Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis.
    Gibb S; Nolan T; South M; Noad L; Bates G; Vidmar S
    J Pediatr; 2004 Mar; 144(3):351-7. PubMed ID: 15001941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improving the cure rate of alarm treatment for monosymptomatic nocturnal enuresis by increasing bladder capacity--a randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Lax H; Hirche H; Bernaerts K; Vandermaelen V; van Gool JD
    J Urol; 2008 Mar; 179(3):1122-6; discussion 1126-7. PubMed ID: 18206946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.
    Ozden C; Ozdal OL; Aktas BK; Ozelci A; Altinova S; Memis A
    Int Urol Nephrol; 2008; 40(3):583-6. PubMed ID: 18320340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in nocturnal bladder capacity during treatment with the bell and pad for monosymptomatic nocturnal enuresis.
    Oredsson AF; Jørgensen TM
    J Urol; 1998 Jul; 160(1):166-9. PubMed ID: 9628642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.
    Saldano DD; Chaviano AH; Maizels M
    Urol Nurs; 2008 Aug; 28(4):263-6. PubMed ID: 18771159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Desmopressin versus behavioral modifications as initial treatment of primary nocturnal enuresis.
    Fera P; Lelis MA; Glashan Rde Q; Pereira SG; Bruschini H
    Urol Nurs; 2011; 31(5):286-9. PubMed ID: 22073899
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diuretic treatment of nocturnal enuresis.
    Nevéus T; Johansson E; Nydahl-Persson K; Peterson H; Hansson S
    Scand J Urol Nephrol; 2005; 39(6):474-8. PubMed ID: 16303723
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
    Yucel S; Kol A; Guntekin E; Baykara M
    Urology; 2011 Mar; 77(3):721-4. PubMed ID: 21215431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
    Rittig N; Hagstroem S; Mahler B; Kamperis K; Siggaard C; Mikkelsen MM; Bower WF; Djurhuus JC; Rittig S
    Neurourol Urodyn; 2014 Jun; 33(5):475-81. PubMed ID: 23765698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of a cure process during alarm treatment for nocturnal enuresis.
    Ikeda K; Koga A; Minami S
    J Clin Psychol; 2006 Oct; 62(10):1245-57. PubMed ID: 16897693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monosymptomatic nocturnal enuresis in pediatric patients: multidisciplinary assessment and effects of therapeutic intervention.
    Fagundes SN; Lebl AS; Azevedo Soster L; Sousa E Silva GJ; Silvares EF; Koch VH
    Pediatr Nephrol; 2017 May; 32(5):843-851. PubMed ID: 27988804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nocturnal enuresis in children.
    Makari J; Rushton HG
    Clin Evid; 2006 Jun; (15):486-95. PubMed ID: 16973021
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment response of an outpatient training for children with enuresis in a tertiary health care setting.
    Cobussen-Boekhorst HJ; van Genugten LJ; Postma J; Feitz WF; Kortmann BB
    J Pediatr Urol; 2013 Aug; 9(4):516-20. PubMed ID: 22738923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of bedwetting.
    Moulden A
    Aust Fam Physician; 2002 Feb; 31(2):161-3. PubMed ID: 11917829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic factors for alarm treatment.
    Rappaport L
    Scand J Urol Nephrol Suppl; 1997; 183():55-7; discussion 57-8. PubMed ID: 9165609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Re: Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis.
    Hemmelmann C; Ziegler A
    BJU Int; 2010 Apr; 105(8):1188-9; author reply 1189. PubMed ID: 22299150
    [No Abstract]   [Full Text] [Related]  

  • 78. Extracorporeal magnetic innervation therapy in children with refractory monosymptomatic nocturnal enuresis.
    Kang SH; Bae JH; Shim KS; Park HS; Cheon J; Lee JG; Yoon DK; Kim JJ; Moon du G
    Urology; 2007 Sep; 70(3):576-80. PubMed ID: 17905120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of 1-deamino 8-D-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis.
    Akoğlu E; Görür S; Atik E; Okuyucu S; Sangün O
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1919-22. PubMed ID: 16901550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.